Acute Autoimmune Leukoencephalopathy Secondary to Adalimumab Therapy.
Sign Up to like & getrecommendations! Published in 2019 at "American Journal of Therapeutics"
DOI: 10.1097/mjt.0000000000000911
Abstract: ment in a subject with autistic disorder and fetishism. J Child Adolesc Psychopharmacol. 2008;18:206–209. 8. Albertini G, Polito E, Sara M, et al. Compulsive masturbation in infantile autism treated by mirtazapine. Ped Neurol. 2006;34:417–418. 9.… read more here.
Keywords: adalimumab therapy; leukoencephalopathy secondary; autism; acute autoimmune ... See more keywords
Cellulitis‐like Sweet Syndrome caused by adalimumab therapy for severe hidradenitis suppurativa
Sign Up to like & getrecommendations! Published in 2020 at "Australasian Journal of Dermatology"
DOI: 10.1111/ajd.13349
Abstract: cebo or etanercept for chronic plaque psoriasis (reSURFACE 1 and reSURFACE 2): results from two randomised controlled, phase 3 trials. Lancet 2017; 390: 276–8. 3. Vaccaro M, Cannav o SP, Imbesi S et al. Increased… read more here.
Keywords: sweet syndrome; like sweet; syndrome caused; caused adalimumab ... See more keywords
Long‐term impact of adalimumab therapy on biomarkers of systemic inflammation in psoriasis: Results of a 2 year study
Sign Up to like & getrecommendations! Published in 2020 at "Dermatologic Therapy"
DOI: 10.1111/dth.14110
Abstract: Psoriasis patients are at increased risk of atherosclerosis, characterized by endothelial dysfunction, linked through systemic inflammation. Anti‐TNF‐a therapy seems to decrease this risk. The purpose of this study was to measure the levels of serum… read more here.
Keywords: psoriasis; adalimumab therapy; systemic inflammation; inflammation psoriasis ... See more keywords
Adalimumab therapy is associated with increased faecal short chain fatty acids in hidradenitis suppurativa
Sign Up to like & getrecommendations! Published in 2022 at "Experimental Dermatology"
DOI: 10.1111/exd.14665
Abstract: Altered gut microbiota composition has been observed in individuals with hidradenitis suppurutiva (HS) and many other inflammatory diseases, including obesity, type 1 and type 2 diabetes. Here, we addressed whether adalimumab, a systemic anti‐inflammatory therapy,… read more here.
Keywords: chain fatty; gut microbiota; therapy; fatty acids ... See more keywords
Anti-TNF-Alpha-Adalimumab Therapy Had Time Lag of Improvement in Synovial Hypertrophy Compared to Rapid Response in Power Doppler Synovial Vascularity
Sign Up to like & getrecommendations! Published in 2017 at "Mediators of Inflammation"
DOI: 10.1155/2017/1658397
Abstract: Objectives The quantification of synovitis is of great significance for follow-up in patients with rheumatoid arthritis (RA). This study aimed to validate the use of power Doppler ultrasonography (PDUS) for evaluating synovial vascularity and synovial… read more here.
Keywords: hypertrophy; vascularity; adalimumab therapy; synovial hypertrophy ... See more keywords
The MAP2K2 gene as Potential Diagnostic Marker in Monitoring Adalimumab Therapy of Psoriatic Arthritis.
Sign Up to like & getrecommendations! Published in 2022 at "Current pharmaceutical biotechnology"
DOI: 10.2174/1389201023666220628111644
Abstract: BACKGROUND MAP kinases are some of the cascades that are specialized in the cell's response to external stimuli. Their impaired functioning can be observed during the course of psoriatic arthritis. Currently, the best-known class of… read more here.
Keywords: map2k2 gene; group; adalimumab therapy; psoriatic arthritis ... See more keywords